• Content Hubs
    • Bupa
    • UnitedHealthcare Global
  • Supplements
  • About
  • Alerts
  • Advertise
  • Events
  • Research
  • Contact
SUBSCRIBE
No Result
View All Result
Health & Protection
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy
Health & Protection
No Result
View All Result

Protection sales continue recovery after year-long slump – Gen Re

by Owain Thomas
25 November 2024
Share on FacebookShare on Twitter

Individual protection sales continued to recover in the third quarter of 2024, slightly outpacing the same period last year for the second consecutive period.

The two periods of slight increases appear to show resilience in the market following four consecutive quarters of steep falls beginning in Q2 2023.

However, the data from Gen Re shows cumulative sales across the first nine months of the year remain below last year’s total after the sharp drop from January to March.

According to the reinsurer’s figures, 503,387 individual protection policies were sold from July to September, 817 more than the 502,570 in the same three months last year.

That followed an uptick of 1,283 from April to June which arrested the previous year-long slump.

Overall, the market remains around 2.5% down with 39,348 fewer sales having been completed in the year to the end of September.

The total of 1,505,965 sales was below the 1,545,313 and 1,594,238 completions during the same periods of 2023 and 2022 respectively.

The value of policies sold also recovered to almost match the same period in 2023, being worth £192m compared to £193m on an annual premium equivalent (APE) basis.

However, the full year total of £575m is also 2.5% down on the £590m value at the same point last year.

 

IP up, life down

The growth in income protection (IP) market continued through the quarter with sales up 7% on an APE basis compared to the same period in 2023, while whole of life plans rose too, although more modestly.

In contrast, term assurance sales fell by 6% and critical illness by 3% on the same measurements.

 

Next Post
There is nothing voluntary about the FCA’s voluntary requirements – Bennett

There is nothing voluntary about the FCA's voluntary requirements - Bennett

FJN Growth Solutions hires Rice and Firkins as executive directors

FJN Growth Solutions hires Rice and Firkins as executive directors

FCA repeated Keydata failings on LCF scandal, warns Complaints Commissioner

MPs label FCA 'incompetent' and call for ban of 'confusing' AR regime

HAVE YOU READ?

The UK Health & Protection Awards 2025 supplement – the winners

The UK Health & Protection Awards 2025 supplement – the winners

1 December 2025

Read more

Vote for the PMI and protection providers giving you the best service

28 November 2025

Read more
Health & Protection

© 2025 Definite Article Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • Terms & Conditions
  • Contact

Follow Healthcare & Protection

X
No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy

No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy